ArticleOncotarget2017

Targeting intercellular adhesion molecule-1 prolongs survival in mice bearing bevacizumab-resistant glioblastoma.

Yuji Piao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.